Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


RDM researchers are leading one of the six new NIHR-BHF COVID-19 projects.

The project takes advantage of novel artificial intelligence (AI) techniques applied to CT chest scans to accurately measure the level of inflammation in the heart which is suspected to be a cause of severe responses to the virus. CT scans are now frequently used to estimate the involvement of the lungs and hearts of COVID-19 patients.

These AI methods were developed by Professor Charalambos Antoniades, who will lead the project with collaborators across the UK.

Linking their results to the data generated in the other Flagship Projects will guide the use of anti-inflammatory drugs in COVID-19 patients. This study will be strengthened by the availability of previous CT scans in many patients with existing heart disease and repeat CT scans after infection has subsided. This will allow a direct comparison of inflammation before, during and after infection to understand whether COVID-19 has lasting effects on heart health and therefore whether these patients should be treated more actively with medicines to reduce their cardiovascular risk.

Similar stories

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

Critical six-week window to ‘reset’ blood pressure after giving birth

Home blood pressure monitors could help mothers significantly lower high blood pressure after pregnancy

Nicola Smart to deliver John French Lecture

The British Atherosclerosis Society's John French Memorial Lecture is named in honour of the Oxford-based pathologist, Dr John French, who made seminal observations and contributions to the field of cardiovascular pathology.